Polypharmacy and medicines optimisation M Duerden, T Avery, R Payne Making it safe and sound. London: The King’s Fund, 2013 | 664 | 2013 |
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 651* | 2021 |
Pulse transit time measured from the ECG: an unreliable marker of beat-to-beat blood pressure RA Payne, CN Symeonides, DJ Webb, SRJ Maxwell Journal of Applied Physiology 100 (1), 136-141, 2006 | 541 | 2006 |
The epidemiology of multimorbidity in primary care: a retrospective cohort study A Cassell, D Edwards, A Harshfield, K Rhodes, J Brimicombe, R Payne, ... British Journal of General Practice 68 (669), e245-e251, 2018 | 488 | 2018 |
The effect of physical multimorbidity, mental health conditions and socioeconomic deprivation on unplanned admissions to hospital: a retrospective cohort study RA Payne, GA Abel, B Guthrie, SW Mercer Cmaj 185 (5), E221-E228, 2013 | 323 | 2013 |
Arterial stiffness and hypertension: emerging concepts RA Payne, IB Wilkinson, DJ Webb Hypertension 55 (1), 9-14, 2010 | 298 | 2010 |
Prevalence of polypharmacy in a Scottish primary care population RA Payne, AJ Avery, M Duerden, CL Saunders, CR Simpson, GA Abel European journal of clinical pharmacology 70, 575-581, 2014 | 278 | 2014 |
UK indices of multiple deprivation-a way to make comparisons across constituent countries easier RA Payne, GA Abel Health Stat Q 53 (22), 2015-2016, 2012 | 267 | 2012 |
Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care RA Payne, GA Abel, AJ Avery, SW Mercer, MO Roland British journal of clinical pharmacology 77 (6), 1073-1082, 2014 | 265 | 2014 |
The epidemiology of polypharmacy RA Payne Clinical medicine 16 (5), 465-469, 2016 | 218 | 2016 |
Adjusted indices of multiple deprivation to enable comparisons within and between constituent countries of the UK including an illustration using mortality rates GA Abel, ME Barclay, RA Payne BMJ open 6 (11), e012750, 2016 | 183 | 2016 |
Polypharmacy: one of the greatest prescribing challenges in general practice RA Payne, AJ Avery British Journal of General Practice 61 (583), 83-84, 2011 | 178 | 2011 |
Association of comorbidity and health service usage among patients with dementia in the UK: a population-based study J Browne, DA Edwards, KM Rhodes, DJ Brimicombe, RA Payne BMJ open 7 (3), e012546, 2017 | 160 | 2017 |
Improving medication management in multimorbidity: development of the MultimorbiditY COllaborative Medication Review And DEcision making (MY COMRADE) intervention using the … C Sinnott, SW Mercer, RA Payne, M Duerden, CP Bradley, M Byrne Implementation Science 10, 1-11, 2015 | 158 | 2015 |
Maternal, newborn, child and adolescent health: Adolescent development World Health Organization World Health Organization. Retrieved from: http://www. who. int …, 2017 | 140 | 2017 |
Effect of antihypertensive medication reduction vs usual care on short-term blood pressure control in patients with hypertension aged 80 years and older: the OPTIMISE … JP Sheppard, J Burt, M Lown, E Temple, R Lowe, R Fraser, J Allen, ... Jama 323 (20), 2039-2051, 2020 | 137 | 2020 |
Polycystic ovary syndrome and autism: a test of the prenatal sex steroid theory A Cherskov, A Pohl, C Allison, H Zhang, RA Payne, S Baron-Cohen Translational psychiatry 8 (1), 136, 2018 | 103 | 2018 |
Cardiovascular risk RA Payne British journal of clinical pharmacology 74 (3), 396-410, 2012 | 103 | 2012 |
Development and validation of the Cambridge Multimorbidity Score RA Payne, SC Mendonca, MN Elliott, CL Saunders, DA Edwards, ... Cmaj 192 (5), E107-E114, 2020 | 94 | 2020 |
ACE inhibitor and angiotensin receptor-II antagonist prescribing and hospital admissions with acute kidney injury: a longitudinal ecological study LA Tomlinson, GA Abel, AN Chaudhry, CR Tomson, IB Wilkinson, ... PLoS One 8 (11), e78465, 2013 | 84 | 2013 |